Insight0

Drug donanemab seen as turning point in dementia fight

By Posted on
Time to Read:-words

The antibody treatment donanemab helps clear the brain of a damaging protein that builds up in Alzheimer’s.

138
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Related Insights:

  1. Drug slows cognitive decline in Alzheimer’s patients, study reveals
  2. New Alzheimer’s drug slows cognitive decline by 35%, trial results show
  3. Protein discovery on human eggs may shed light on unexplained infertility
  4. NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say